0001178913-22-003374.txt : 20220909 0001178913-22-003374.hdr.sgml : 20220909 20220909160915 ACCESSION NUMBER: 0001178913-22-003374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220907 FILED AS OF DATE: 20220909 DATE AS OF CHANGE: 20220909 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Santora Arthur C II CENTRAL INDEX KEY: 0001904746 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38556 FILM NUMBER: 221236302 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH STREET 2: MINRAV BUILDING, FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Entera Bio Ltd. CENTRAL INDEX KEY: 0001638097 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 BUSINESS PHONE: 972-2-532-7151 MAIL ADDRESS: STREET 1: KIRYAT HADASSAH, MINRAV BUILDING STREET 2: FIFTH FLOOR CITY: JERUSALEM STATE: L3 ZIP: 9112002 4 1 ownership.xml X0306 4 2022-09-07 0 0001638097 Entera Bio Ltd. ENTX 0001904746 Santora Arthur C II KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR JERUSALEM L3 9112002 ISRAEL 0 1 0 0 Chief Medical Officer Stock Option (right to buy) 2.86 2022-09-07 4 A 0 20000 0 A 2031-03-31 Ordinary Shares, par value NIS 0.0000769 per share 20000 20000 D This grant of options was approved by the Board of Directors of Entera Bio Ltd. (the "Company") on March 31, 2021, subject to approval by the Company's shareholders, which was obtained on September 7, 2022. The options vest over a four-year period that commenced on March 31, 2021, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period. /s/ Dana Yaacov-Garbeli, Attorney-in-Fact 2022-09-09